In a recent study that evaluated cell-based therapies for acute and chronic liver failure, survival data of Fah−/− mice was compared after transplantation of primary hepatocytes, fetal liver cells, iHepSCs, and bone marrow stem cells51. The gene discussed is FAH; the disease is chronic liver failure.